These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 33585528)

  • 1. Hypothesis: Mechanisms That Prevent Recovery in Prolonged ICU Patients Also Underlie Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Stanculescu D; Larsson L; Bergquist J
    Front Med (Lausanne); 2021; 8():628029. PubMed ID: 33585528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theory: Treatments for Prolonged ICU Patients May Provide New Therapeutic Avenues for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Stanculescu D; Larsson L; Bergquist J
    Front Med (Lausanne); 2021; 8():672370. PubMed ID: 34026797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspective: Drawing on Findings From Critical Illness to Explain Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Stanculescu D; Bergquist J
    Front Med (Lausanne); 2022; 9():818728. PubMed ID: 35345768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways.
    Morris G; Anderson G; Maes M
    Mol Neurobiol; 2017 Nov; 54(9):6806-6819. PubMed ID: 27766535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS.
    Maes M; Twisk FN
    Neuro Endocrinol Lett; 2009; 30(6):677-93. PubMed ID: 20038921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.
    Morris G; Maes M
    Metab Brain Dis; 2014 Mar; 29(1):19-36. PubMed ID: 24557875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.
    Maes M; Bosmans E; Kubera M
    Neuro Endocrinol Lett; 2015; 36(5):439-46. PubMed ID: 26707044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative and Nitrosative Stress and Immune-Inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).
    Morris G; Maes M
    Curr Neuropharmacol; 2014 Mar; 12(2):168-85. PubMed ID: 24669210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).
    Morris G; Berk M; Galecki P; Maes M
    Mol Neurobiol; 2014 Apr; 49(2):741-56. PubMed ID: 24068616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups.
    Twisk FN
    Front Physiol; 2014; 5():109. PubMed ID: 24734022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms Explaining Muscle Fatigue and Muscle Pain in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a Review of Recent Findings.
    Gerwyn M; Maes M
    Curr Rheumatol Rep; 2017 Jan; 19(1):1. PubMed ID: 28116577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome.
    Maes M
    Mod Trends Pharmacopsychiatry; 2013; 28():162-74. PubMed ID: 25224898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS.
    Twisk FN; Maes M
    Neuro Endocrinol Lett; 2009; 30(3):284-99. PubMed ID: 19855350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.
    Morris G; Maes M
    Metab Brain Dis; 2013 Dec; 28(4):523-40. PubMed ID: 22718491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
    Domingo JC; Cordobilla B; Ferrer R; Giralt M; Alegre-Martín J; Castro-Marrero J
    Antioxid Redox Signal; 2021 Jun; 34(18):1420-1427. PubMed ID: 33353469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Maes M; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E
    Med Sci Monit; 2011 Apr; 17(4):SC11-5. PubMed ID: 21455120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.
    Morris G; Maes M
    BMC Med; 2013 Sep; 11():205. PubMed ID: 24229326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder.
    Maes M; Mihaylova I; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E
    Neuro Endocrinol Lett; 2009; 30(4):470-6. PubMed ID: 20010505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
    Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
    J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.